Hans Gelderblom

Researcher Next ID · RN-003325

Researcher · Medicine

Leiden, Netherlands

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Sarcoma Diagnosis and Treatment

Gastrointestinal Tumor Research and Treatment

Colorectal Cancer Treatments and Studies

Bone Tumor Diagnosis and Treatments

Cancer Genomics and Diagnostics

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy096
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70063-4
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)60651-5
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)61857-1
Cremophor EL
European Journal of Cancer · 2001 · https://doi.org/10.1016/s0959-8049(01)00171-x

No projects listed.